Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) EBIT Margin Growth (3y) (2012 - 2026)

Analysis

Haemonetics (HAE) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -201.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 722.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 162.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 586.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 887.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -1,075.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 963.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 244.00
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn -31.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -31.00
Mar 28, 2026 -1,823.00
Dec 27, 2025 571.00
Sep 27, 2025 216.00
Jun 28, 2025 499.00
Mar 29, 2025 1,433.00
Dec 28, 2024 321.00
Sep 28, 2024 475.00
Jun 29, 2024 1,122.00
Mar 30, 2024 1,813.00
Dec 30, 2023 -314.00
Sep 30, 2023 -1,696.00
Jul 1, 2023 1,125.00
Apr 1, 2023 68.00
Dec 31, 2022 -162.00
Oct 1, 2022 -398.00
Jul 2, 2022 1,735.00
Apr 2, 2022 -232.00
Jan 1, 2022 228.00
Oct 2, 2021 -58.00